Agree Graeme, the planets appear to be aligning for CZD. Any announcement on agreements and royalties and the share price will increase substantially. This sentiment excludes the potential of AOD which David Kenley clearly believes that he can extract value from. Let's not forget CZD was once a 2-3 dollar company. I was skeptical at the AGM when the conpany still was following the AOD path to commercial benefit for shareholders. But the company is ticking the boxes going forward. Was once told by a broker that broking firms do not look at the multitude of biotechs until their market cap is 80-100 m. I believe they will start looking at CZD in the short to medium term. Very positive, yes I am!!
Add to My Watchlist
What is My Watchlist?